Role of Bone Marrow-Derived Lymphatic Endothelial Progenitor Cells for Lymphatic Neovascularization

Trends in Cardiovascular Medicine

Volumn 21, Issue 5, 2011, Pages 135-140

  Park, Changwon ^a   Lee, Ji Yoon ^b   Yoon, Young sup ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; ENDOTHELIUM CELL; HUMAN; IMMUNITY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOSARCOMA; LYMPHEDEMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; WOUND HEALING;

BONE MARROW CELLS; ENDOTHELIAL CELLS; HUMANS; LYMPHATIC VESSELS; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 84862740046     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.04.002     Document Type: Review

References (53)

1. Abtahian F., Guerriero A., Sebzda E., et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003, 299:247-251.
2. Asahara T., Kawamoto A., Masuda H. Concise review: Circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011, 29:1650-1655.
3. Bertozzi C.C., Schmaier A.A., Mericko P., et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010, 116:661-670.
4. + progenitors. Exp Hematol 2006, 34:851-859.
5. Cao R., Björndahl M.A., Gallego M.I., et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 2006, 107:3531-3536.
6. Cho C.H., Sung H.K., Kim K.T., et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A 2006, 103:4946-4951.
7. Choi I., Lee S., Kyoung Chung H., et al. 9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: Therapeutic implications of 9-cis retinoic acid for secondary lymphedema. Circulation 2012, 125:872-882.
8. Conrad C., Niess H., Huss R., et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation 2009, 119:281-289.
9. Cursiefen C., Chen L., Borges L.P., et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004, 113:1040-1050.
10. Dumont D.J., Jussila L., Taipale J., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998, 282:946-949.
11. Fantin A., Vieira J.M., Gestri G., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
12. François M., Caprini A., Hosking B., et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008, 456:643-647.
13. Göthert J.R., Gustin S.E., van Eekelen J.A., et al. Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004, 104:1769-1777.
14. He Y., Rajantie I., Ilmonen M., et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004, 64:3737-3740.
15. + progenitors in vitro. J Immunol 2005, 174:2552-2562.
16. Hong Y.K., Harvey N., Noh Y.H., et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dynam Off Publ Am Assoc Anatomists 2002, 225:351-357.
17. Ichise H., Ichise T., Ohtani O., Yoshida N. Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 2009, 136:191-195.
18. Johnson N.C., Dillard M.E., Baluk P., et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 2008, 22:3282-3291.
19. Kalof A.N., Cooper K. D2-40 immunohistochemistry-So far!. Adv Anat Pathol 2009, 16:62-64.
20. Kanady J.D., Dellinger M.T., Munger S.J., et al. Connexin37 and connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 2011, 354:253-266.
21. Karkkainen M.J., Haiko P., Sainio K., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004, 5:74-80.
22. Karpanen T., Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Review Pathol 2008, 3:367-397.
23. Karpanen T., Egeblad M., Karkkainen M.J., et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001, 61:1786-1790.
24. Kato Y., Fujita N., Kunita A., et al. Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem 2003, 278:51599-51605.
25. Kerjaschki D., Huttary N., Raab I., et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006, 12:230-234.
26. Krause D.S. Plasticity of marrow-derived stem cells. Gene Ther 2002, 9:754-758.
27. Larrivée B., Niessen K., Pollet I., et al. Minimal contribution of marrow-derived endothelial precursors to tumor vasculature. J Immunol 2005, 175:2890-2899.
28. Lee J.Y., Park C., Cho Y.P., et al. Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation 2010, 122:1413-1425.
29. Lee S., Kang J., Yoo J., et al. Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 2009, 113:1856-1859.
30. Maruyama K., Ii M., Cursiefen C., et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005, 115:2363-2372.
31. Nagy J.A., Vasile E., Feng D., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002, 196:1497-1506.
32. Niessen K., Zhang G., Ridgway J.B., et al. The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 2011, 118:1989-1997.
33. Norrmén C., Ivanov K.I., Cheng J., et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 2009, 185:439-457.
34. Petrova T.V., Karpanen T., Norrmén C., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004, 10:974-981.
35. Petrova T.V., Mäkinen T., Mäkelä T.P., et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the prox-1 homeobox transcription factor. EMBO J 2002, 21:4593-4599.
36. Purhonen S., Palm J., Rossi D., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008, 105:6620-6625.
37. Religa P., Cao R., Bjorndahl M., et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 2005, 106:4184-4190.
38. Saaristo A., Tammela T., Farkkilā A., et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol 2006, 169:1080-1087.
39. Saaristo A., Tammela T., Timonen J., et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J 2004, 18:1707-1709.
40. + lymphatic/vascular endothelial precursor cells. Blood 2003, 101:168-172.
41. Schacht V., Ramirez M.I., Hong Y.K., et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003, 22:3546-3556.
42. Sleeman J.P., Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer J Int Cancer 2009, 125:2747-2756.
43. Spyridonidis A., Zeiser R., Follo M., et al. Stem cell plasticity: The debate begins to clarify. Stem Cells Rev 2005, 1:37-43.
44. Suzuki-Inoue K., Inoue O., Ding G., et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010, 285:24494-24507.
45. Szuba A., Skobe M., Karkkainen M.J., et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 2002, 16:1985-1987.
46. Tammela T., Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 2010, 140:460-476.
47. Uhrin P., Zaujec J., Breuss J.M., et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010, 115:3997-4005.
48. Wigle J.T., Harvey N., Detmar M., et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002, 21:1505-1513.
49. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999, 98:769-778.
50. Yamazaki T., Yoshimatsu Y., Morishita Y., et al. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells Devoted Mol Cell Mech 2009, 14:425-434.
51. Yoon Y.S., Murayama T., Gravereaux E., et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003, 111:717-725.
52. Zhang L., Zhou F., Han W., et al. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res 2010, 20:1319-1331.
53. Zumsteg A., Baeriswyl V., Imaizumi N., et al. Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE 2009, 4:e7067.